Australian Female Infertility Diagnosis and Treatment Market Trends, Size, Competitive Analysis and Forecast 2019-2025
Australian female infertility diagnosis and treatment market is expected to witness a significant growth with the CAGR of 3.8% during the forecast period. The inability to conceive may occur in both men and women, however, infertility among women is more common. There are several factors that cause infertility among women such as exceeding 35 years of age, unhealthy lifestyle and genetic disorders. The market is driven by the growth in the number of infertility cases along with the extensive development of advanced technologies such as Assisted Reproductive Technology (ART) and Intrauterine Insemination (IUI).
In addition, the female
infertility diagnosis and treatment diagnosis and treatment market are
also growing due to the increasing trend of surrogacy, inclination towards
in-vitro fertilization (IVF) treatment and rising population of women marrying
in the late 30s. Change in the lifestyle among women is also considered as the
major factor that tends to affect female fertility. The consumption of
inadequate diet and body weight plays a major role in growing infertility among
women. Overweight or underweight is one of the factors that affect the hormone
production and affect the ovulation process.
To Request a Sample of our Report on Australian Female Infertility Diagnosis and Treatment Market: https://www.omrglobal.com/request-sample/australia-female-infertility-market
Australian female infertility
diagnosis and treatment market is segmented on the basis of diagnosis,
treatment type, and end-user. Based on the diagnosis, the market is segmented
into ovulation testing, hysterosalpingography (HSG), hysteroscopy, imaging
testing, ovarian reserve testing, hormonal level testing, genetic testing, and
others (laparoscopy). Based on the treatment type, the market is segmented into
drugs, surgery, intrauterine insemination (IUI), and assisted reproductive
technology (ART). Based on the end-user, the market is segmented into hospitals
and clinics, homecare, and pathology and diagnostic center.
(Get 15% Discount on Buying this Report)
A
full Report of Australian Female Infertility Diagnosis and Treatment Market is
Available @ https://www.omrglobal.com/industry-reports/australia-female-infertility-market
Australian Female Infertility Diagnosis and Treatment
Market Segmentation
By Diagnosis
·
Ovulation Testing
·
Hysterosalpingography (HSG)
·
Hysteroscopy
·
Imaging Testing
·
Ovarian Reserve Testing
·
Hormonal Level Testing
·
Genetic Testing
·
Others (Laparoscopy)
By Treatment
·
Drugs
·
Surgery
·
Intrauterine Insemination (IUI)
·
Assisted Reproductive Technology (ART)
By End-User
·
Hospitals and Clinics
·
Homecare
·
Pathology and Diagnostic Centers
Company Profiles
·
Genea Ltd.
·
Bayer AG
·
Pfizer
·
Merck
KGaA
·
Church & Dwight Co., Inc.
·
Vitrolife
·
Cook Medical, Inc.
·
Eli Lilly & Co.
·
GlaxoSmithKline Plc.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment